CollPlant Biotechnologies (CLGN) Depreciation and Depletion (2019 - 2021)
CollPlant Biotechnologies (CLGN) posted Depreciation and Depletion of $224000.0 for Q4 2021, up 13.71% on a QoQ basis from $197000.0 in Q3 2021, and up 34.94% year-over-year from $166000.0 in Q4 2020.
CollPlant Biotechnologies (CLGN) Depreciation and Depletion (2019 - 2021) Analysis & Trends
CollPlant Biotechnologies' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $224000.0 for Q4 2021.
- Quarterly Depreciation and Depletion rose 34.94% year-over-year to $224000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $754000.0 (up 14.24% YoY) and the FY2025 annual result came in at $854000.0, down 12.95% from the prior year.
- Depreciation and Depletion was $224000.0 for Q4 2021 at CollPlant Biotechnologies, up from $197000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $224000.0 in Q4 2021 and bottomed at $97000.0 in Q1 2019.
- A 3-year average of $162000.0 and a median of $165000.0 in 2020 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 69.07% in 2020, while the deepest fall reached 1.78% in 2020.
- CollPlant Biotechnologies' Depreciation and Depletion stood at $169000.0 in 2019, then decreased by 1.78% to $166000.0 in 2020, then jumped by 34.94% to $224000.0 in 2021.
- Business Quant data shows CLGN's Depreciation and Depletion at $224000.0 in Q4 2021, $197000.0 in Q3 2021, and $166000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 224,000.00 |
| Dec 31, 2021 | 224,000.00 |
| Sep 30, 2021 | 197,000.00 |
| Sep 30, 2021 | 197,000.00 |
| Dec 31, 2020 | 166,000.00 |
| Dec 31, 2020 | 166,000.00 |
| Sep 30, 2020 | 167,000.00 |
| Sep 30, 2020 | 167,000.00 |
| Jun 30, 2020 | 163,000.00 |
| Jun 30, 2020 | 163,000.00 |
| Mar 31, 2020 | 164,000.00 |
| Mar 31, 2020 | 164,000.00 |
| Dec 31, 2019 | 169,000.00 |
| Dec 31, 2019 | 169,000.00 |
| Sep 30, 2019 | 142,000.00 |
| Sep 30, 2019 | 142,000.00 |
| Jun 30, 2019 | 131,000.00 |
| Jun 30, 2019 | 131,000.00 |
| Mar 31, 2019 | 97,000.00 |
| Mar 31, 2019 | 97,000.00 |